Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Summary

The purpose of this study is to study the effect of monthly dosing with a single dose of Lu AF20513, with and without booster vaccine, on antibody response.

Timeline

Start

2018-12-12

Primary completion

2019-06-27

Completion

2019-06-27

Outcome

Outcome not reported

Stopped: “New data: The study was terminated based on new efficacy data from another study”

Drugs

Indications